OLIVOLA, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 2.257
EU - Europa 147
AS - Asia 74
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.482
Nazione #
US - Stati Uniti d'America 2.254
IE - Irlanda 38
SG - Singapore 37
SE - Svezia 25
DE - Germania 21
CN - Cina 18
IT - Italia 17
UA - Ucraina 11
GB - Regno Unito 10
IN - India 10
RU - Federazione Russa 10
FR - Francia 7
KR - Corea 5
CA - Canada 3
FI - Finlandia 3
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
AT - Austria 1
CH - Svizzera 1
HK - Hong Kong 1
JP - Giappone 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.482
Città #
Wilmington 794
Houston 628
Woodbridge 316
Fairfield 80
Chandler 72
Ashburn 59
Seattle 37
Dublin 34
Singapore 33
Cambridge 28
Ann Arbor 27
Medford 25
Santa Clara 17
Lawrence 12
New York 11
Dearborn 10
Beijing 9
Rome 9
Pune 8
San Diego 8
Menlo Park 6
Jacksonville 5
London 4
Milan 4
Munich 4
Norwalk 4
Philadelphia 4
Creede 3
Palo Alto 3
Redwood City 3
Seoul 3
Boardman 2
Brno 2
Falls Church 2
Moscow 2
Nanjing 2
Shenzhen 2
Toronto 2
Washington 2
Changsha 1
Esslingen am Neckar 1
Etobicoke 1
Hefei 1
Helsinki 1
Kilburn 1
Kunming 1
Lausanne 1
Miami 1
Nagold 1
Nuremberg 1
Phoenix 1
Prescot 1
Saint Petersburg 1
San Francisco 1
Shanghai 1
Southwark 1
Tokyo 1
Verona 1
Villa Castelli 1
Wuhan 1
Totale 2.297
Nome #
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 430
Catecholamine-based treatment in AD patients: expectations and delusions 365
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 320
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 312
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 261
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 257
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 247
Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies (Neurological Sciences, (2019), 40, 9, (1917-1923), 10.1007/s10072-019-03920-5) 125
Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies 94
Validation of the Italian version of the PSP Quality of Life questionnaire 38
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 38
An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease 34
Effects of prismatic lenses on lateral axial dystonia in Parkinson's disease: a pilot study 26
Totale 2.547
Categoria #
all - tutte 6.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020691 0 0 52 70 61 71 70 71 88 85 60 63
2020/2021563 68 69 70 63 62 63 68 49 12 12 25 2
2021/2022137 1 5 5 11 2 18 4 5 10 15 22 39
2022/2023173 13 22 8 16 19 35 19 14 17 0 4 6
2023/202479 13 3 7 1 13 30 1 1 1 2 0 7
2024/202583 4 50 29 0 0 0 0 0 0 0 0 0
Totale 2.547